Multiplicom sales and marketing update

Multiplicom launched genomic and somatic mutation detection kits based on its MASTR technology for investigational use. Separate MASTR kits were launched to detect genomic mutations for diseases including mucovisidosis, Marfan syndrome, Alport syndrome, polycystic kidney disease, familial Mediterranean fever and Duchenne muscular dystrophy. Multiplicom also launched the EGFR MASTR somatic mutation kit to identify mutations in exons 18-21 of the EGFR gene. The company is seeking CE Mark approval for the products, which it expects in early 2013. The company declined to provide details. ...